{"schema_version":"secwatch.filing_event.v1","accession":"0001079973-25-000308","form_type":"8-K","ticker":"CDIO","cik":"0001870144","company_name":"Cardio Diagnostics Holdings, Inc.","filed_at":"2025-02-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.427379+00:00","generated_at":"2026-05-26T07:13:49.019098+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Cardio Diagnostics provides investor presentation; no material new facts disclosed","bullets":["Company filed an Investor Presentation dated February 2025 under Item 7.01.","Presentation focuses on epigenetics and AI for cardiovascular medicine but contains no specific financial or operational metrics.","No changes to guidance, revenue, EPS, or business outlook were reported.","Presentation is available on the company's website for investor use."],"urls":{"canonical":"https://secwatch.observer/filing/0001079973-25-000308","json":"https://secwatch.observer/filing/0001079973-25-000308.json","markdown":"https://secwatch.observer/filing/0001079973-25-000308.md","text":"https://secwatch.observer/filing/0001079973-25-000308.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1870144/000107997325000308/0001079973-25-000308-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1870144/000107997325000308/cdio_8k-022125.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T07:13:49.019098+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}